In very rapidly progressive/poorly differentiated hepatocellular cancer, would you use the targeted options (sorafenib/lenvatinib) or would you try a traditional cytotoxic regimen?   

Answer from: Medical Oncologist at Community Practice
Medical Oncologist at Regional Cancer Care Associates, LLC
Is there any role for VEGF inhibitors along with a...
Medical Oncologist at NYU Winthrop Hospital
Sign in or Register to read more